{ "generated": "2026-08-08T04:45:39.859666+00:00", "method": "Out-of-sample verified weighted portfolio: sleeve weights trained on the first 70% of months only, verified on the final 30% (OOS Sharpe 1.9). Spread costs included, Dukascopy tick-derived data, 1% risk base. Member configs proprietary.", "config": { "engine": "GTX PORTFOLIO 2014 6 weighted verified configs", "timeframe_min": 60, "filters": "PROPRIETARY (vaulted)" }, "sample": { "trades": 8584, "months": 224, "wins": 200, "breakevens": 675, "losses": 49 }, "metrics": { "win_rate_decided_pct": 80.3, "no_loss_rate_pct": 94.7, "profit_factor": 3.56, "sharpe_ratio": 1.66, "sortino_ratio": 3.88, "calmar_ratio": 2.11, "max_drawdown_pct": 2.05, "cagr_pct": 4.3, "total_return_pct": 120.5, "best_month_pct": 3.23, "worst_month_pct": -1.77, "positive_months_pct": 67.9 }, "benchmarks": [ { "name": "Systematic trend following", "win_rate": "40-50%", "sharpe": "0.8-1.2", "ma Author: Andrew Stewart Caldin, Independent Researcher, UK. Part of the E8 Intelligence Research series. Platform: e8intelligence.com
No takes yet. Share an insight, caveat, or question.
Andrew Stewart Caldin (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: